Distinct subjects for predicate <http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PrecipitantDrugOfInteraction> sorted by frequency

ResourceCount
amiodarone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
amiodarone is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C91
amiodarone is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
amiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
amiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C91
amiodarone is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
amiodarone is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
amiodarone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
aripiprazole increases the AUC of escitalopram1
aripiprazole increases the AUC of venlafaxine1
atazanavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
atazanavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
atazanavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
atazanavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
atorvastatin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
atorvastatin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
bupropion increases the AUC of desipramine1
bupropion is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
bupropion is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
cimetidine increases the AUC of amitriptyline1
cimetidine increases the AUC of citalopram1
cimetidine increases the AUC of doxepin1
cimetidine increases the AUC of erythrohydrobupropion1
cimetidine increases the AUC of escitalopram1
cimetidine increases the AUC of imipramine1
cimetidine increases the AUC of mirtazapine1
cimetidine increases the AUC of paroxetine1
cimetidine increases the AUC of quetiapine1
cimetidine increases the AUC of sertraline1
cimetidine increases the AUC of theophylline1
cimetidine increases the AUC of threohydrobupropion1
cimetidine increases the AUC of venlafaxine1
cimetidine increases the AUC of ziprasidone1
cimetidine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
cimetidine is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
cimetidine is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
cimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
cimetidine is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
cimetidine is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
cimetidine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
cinacalcet is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
cinacalcet is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
ciprofloxacin is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
ciprofloxacin is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
ciprofloxacin is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
citalopram increases the AUC of desipramine1
clarithromycin increases the AUC of atorvastatin1
clarithromycin increases the AUC of lansoprazole1
clarithromycin increases the AUC of midazolam1
clarithromycin increases the AUC of pravastatin1
clarithromycin increases the AUC of trazodone1
clarithromycin increases the AUC of triazolam1
clarithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
clarithromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
clarithromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
clarithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
clopidogrel increases the AUC of bupropion1
desvenlafaxine increases the AUC of desipramine1
diltiazem increases the AUC of beta-hydroxy-lovastatin1
diltiazem increases the AUC of imipramine1
diltiazem increases the AUC of midazolam1
diltiazem increases the AUC of simvastatin1
diltiazem increases the AUC of triazolam1
diltiazem is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
diltiazem is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
diphenhydramine increases the AUC of venlafaxine1
duloxetine increases the AUC of theophylline1
duloxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
duloxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
erythromycin increases the AUC of alprazolam1
erythromycin increases the AUC of atorvastatin1
erythromycin increases the AUC of beta-hydroxy-simvastatin1
erythromycin increases the AUC of midazolam1
erythromycin increases the AUC of quetiapine1
erythromycin increases the AUC of simvastatin1
erythromycin increases the AUC of triazolam1
erythromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
erythromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
fluconazole increases the AUC of fluvastatin1
fluconazole increases the AUC of midazolam1
fluconazole increases the AUC of triazolam1
fluconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
fluconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C91
fluconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
fluconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C91
fluconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
fluconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
fluoxetine increases the AUC of alprazolam1
fluoxetine increases the AUC of desipramine1
fluoxetine increases the AUC of imipramine1
fluoxetine increases the AUC of olanzapine1
fluoxetine increases the AUC of propafenone1
fluoxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
fluoxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
fluvoxamine increases the AUC of clozapine1
fluvoxamine increases the AUC of duloxetine1
fluvoxamine increases the AUC of lansoprazole1
fluvoxamine increases the AUC of mexiletine1
fluvoxamine increases the AUC of omeprazole1
fluvoxamine increases the AUC of quinidine1
fluvoxamine increases the AUC of theophylline1
fluvoxamine increases the AUC of thioridazine1
fluvoxamine increases the AUC of tolbutamide1
fluvoxamine is predicted to reduce the clearance of citalopram by inhibition of CYP2C191
fluvoxamine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
fluvoxamine is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C91
fluvoxamine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
fluvoxamine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
fluvoxamine is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C91
fluvoxamine is predicted to reduce the clearance of sertraline by inhibition of CYP2C191
gemfibrozil is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C81
iloperidone is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
iloperidone is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
indinavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
indinavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
indinavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
indinavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
itraconazole increases the AUC of 3alpha-hydroxypravastatin1
itraconazole increases the AUC of alprazolam1
itraconazole increases the AUC of atorvastatin1
itraconazole increases the AUC of beta-hydroxy-lovastatin1
itraconazole increases the AUC of lovastatin1
itraconazole increases the AUC of midazolam1
itraconazole increases the AUC of pravastatin1
itraconazole increases the AUC of rosuvastatin1
itraconazole increases the AUC of triazolam1
itraconazole increases the AUC of zolpidem1
itraconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
itraconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
ketoconazole increases the AUC of O-desmethylvenlafaxine1
ketoconazole increases the AUC of alprazolam1
ketoconazole increases the AUC of amitriptyline1
ketoconazole increases the AUC of desvenlafaxine1
ketoconazole increases the AUC of imipramine1
ketoconazole increases the AUC of midazolam1
ketoconazole increases the AUC of simvastatin1
ketoconazole increases the AUC of triazolam1
ketoconazole increases the AUC of venlafaxine1
ketoconazole increases the AUC of zolpidem1
ketoconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
ketoconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
lansoprazole increases the AUC of lansoprazole1
mexiletine is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
mexiletine is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
mexiletine is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
modafinil is predicted to reduce the clearance of citalopram by inhibition of CYP2C191
modafinil is predicted to reduce the clearance of sertraline by inhibition of CYP2C191
modafinil-sulfone is predicted to reduce the clearance of citalopram by inhibition of CYP2C191
modafinil-sulfone is predicted to reduce the clearance of sertraline by inhibition of CYP2C191
nefazodone increases the AUC of alprazolam1
nefazodone increases the AUC of midazolam1
nefazodone increases the AUC of triazolam1
nefazodone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
nefazodone is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
nefazodone is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
nefazodone is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
norfloxacin is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
norfloxacin is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
norfloxacin is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
omeprazole increases the AUC of escitalopram1
omeprazole is predicted to reduce the clearance of citalopram by inhibition of CYP2C191
omeprazole is predicted to reduce the clearance of sertraline by inhibition of CYP2C191
paroxetine increases the AUC of desipramine1
paroxetine increases the AUC of duloxetine1
paroxetine increases the AUC of imipramine1
paroxetine increases the AUC of mirtazapine1
paroxetine increases the AUC of nortriptyline1
paroxetine increases the AUC of paliperidone1
paroxetine increases the AUC of risperidone1
paroxetine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
paroxetine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
prasugrel increases the AUC of bupropion1
propafenone is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
propafenone is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
propafenone is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
quinidine increases the AUC of venlafaxine1
quinidine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
quinidine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
ranolazine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
ranolazine is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
ranolazine is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
ranolazine is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
ritonavir increases the AUC of trazodone1
ritonavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
ritonavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
ritonavir is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
ritonavir is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
ritonavir is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
sertraline increases the AUC of desipramine1
sertraline is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
sertraline is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
telithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
telithromycin is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
telithromycin is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
telithromycin is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
terbinafine increases the AUC of paroxetine1
terbinafine increases the AUC of venlafaxine1
terbinafine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
terbinafine is predicted to reduce the clearance of venlafaxine by inhibition of CYP2D61
teriflunomide is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C91
teriflunomide is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C91
ticlopidine increases the AUC of bupropion1
trimethoprim is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C81
valproate increases the AUC of hydroxybupropion1
venlafaxine increases the AUC of desipramine1
venlafaxine increases the AUC of haloperidol1
venlafaxine increases the AUC of imipramine1
venlafaxine increases the AUC of risperidone1
venlafaxine is predicted to reduce the clearance of aripiprazole by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of clozapine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of desipramine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of duloxetine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of escitalopram by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of fluoxetine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of fluvoxamine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of iloperidone by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of mirtazapine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of olanzapine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of paroxetine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of perphenazine by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of r-citalopram by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of risperidone by inhibition of CYP2D61
venlafaxine is predicted to reduce the clearance of thioridazine by inhibition of CYP2D61
verapamil increases the AUC of imipramine1
verapamil increases the AUC of risperidone1
verapamil is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of alprazolam by inhibition of CYP3A51
verapamil is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of duloxetine by inhibition of CYP1A21
verapamil is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP1A21
verapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A51
verapamil is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of perphenazine by inhibition of CYP1A21
verapamil is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
verapamil is predicted to reduce the clearance of zolpidem by inhibition of CYP3A51
voriconazole is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of citalopram by inhibition of CYP2C191
voriconazole is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C91
voriconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C91
voriconazole is predicted to reduce the clearance of sertraline by inhibition of CYP2C191
voriconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
voriconazole is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of citalopram by inhibition of CYP2C191
voriconazole-n-oxide is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C91
voriconazole-n-oxide is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C91
voriconazole-n-oxide is predicted to reduce the clearance of sertraline by inhibition of CYP2C191
voriconazole-n-oxide is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
voriconazole-n-oxide is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of alprazolam by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of aripiprazole by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of atorvastatin by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of clozapine by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of escitalopram by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of eszopiclone by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C91
zafirlukast is predicted to reduce the clearance of fluvastatin by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of haloperidol by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of iloperidone by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of lovastatin by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of mirtazapine by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of nefazodone by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of perphenazine by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of r-citalopram by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of reduced-haloperidol by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of risperidone by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C91
zafirlukast is predicted to reduce the clearance of simvastatin by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of trazodone by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of triazolam by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of venlafaxine by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of zaleplon by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of ziprasidone by inhibition of CYP3A41
zafirlukast is predicted to reduce the clearance of zolpidem by inhibition of CYP3A41